Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12049608 | 0.77 | CES2 (0.44) | CES2CES1 | |
| SCHEMBL30682727 | 0.73 | PDE2A (0.47) | CES2CES1 | |
| SCHEMBL16956342 | 0.73 | CES2 (0.41) | CES2CES1 | |
| SCHEMBL17553266 | 0.73 | CES2 (0.41) | CES2CES1 | |
| SCHEMBL4193634 | 0.73 | CES2 (0.41) | CES2CES1 | |
| SCHEMBL24989671 | 0.73 | CES2 (0.41) | CES2CES1 | |
| SCHEMBL9985396 | 0.73 | PDE2A (0.47) | CES2CES1 | |
| SCHEMBL7801426 | 0.73 | PDE2A (0.47) | CES2CES1 | |
| SCHEMBL13778130 | 0.73 | PDE2A (0.47) | CES2CES1 | |
| SCHEMBL27826253 | 0.73 | CES2 (0.41) | CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10322110-B2 | Imidazole-based antimicrobial agents | PROCOMCURE BIOTECH GMBH (AT) | 2019-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10322110-B2 | Imidazole-based antimicrobial agents | ARG1, SLC11A2, IKZF3 | CES2 2964/4885CES1 2497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.